Snacks and savory categories represent significant opportunities for innovation
Exactly how GLP-1R agonists may be having their neuroprotective effect in the models of Parkinsons is still being determined
These drugs mimic GLP-1s effects, slowing digestion, reducing appetite, and helping people control blood sugar and weight
To manage and treat back pain well, it's important to know what causes it
Next-generation agents, including triple agonists such as retatrutide, extend beyond GLP-1 and GIP to include glucagon receptor activation, introducing a new dimension of energy expenditure and metabolic regulation
Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats